This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
RoActemra (tocilizumab) approved by EMA for use in severe COVID-19
Read more
mRNA-1273 vaccine associated with lower risk of COVID-19 outcomes than BNT162b
Read more
Diabetes-associated ocular complication risk higher in children with type 2 than type 1 disease
Read more
Abnormal axis and LBBB on an ECG predictive of COVID-19 hospital mortality
Read more
Comirnaty COVID-19 booster shows greater than 90% effectiveness in over 50s
Read more
Podcast: Self-management strategies in inflammatory arthritis
Read more
Omicron variant nearly three-times more likely to cause re-infection
Read more
Ultrasound imaging of value for diagnosis of Achilles tendon rupture in ED
Read more
Opioid treatment infrequently started after suspected overdose visit to ED
Read more
Allergen immunotherapy effectiveness confirmed in long-term real-world study
Read more
Skyrizi receives MHRA approval for psoriatic arthritis
Read more
Xevudy (sotrovimab) approved by MHRA for mild to moderate COVID-19
Read more
Button battery ingestion in children: A growing problem
Read more
RAAS inhibition reduces COVID-19 mortality within intensive care
Read more
World AIDS Day seeks to end inequality
Read more
Analysis shows skin peanut allergy patch safe and well tolerated over 3-year period
Read more
Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema
Read more
Page 63 of 201
« First
«
...
10
20
30
...
61
62
63
64
65
...
70
80
90
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
x
Search for: